We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$479M
AUM Growth
-$5.04M
Cap. Flow
+$8.34M
Cap. Flow %
1.74%
Top 10 Hldgs %
67.05%
Holding
98
New
1
Increased
4
Reduced
1
Closed
5

Top Buys

1
PROK icon
ProKidney
PROK
+$17.4M
2
GPGI
GPGI Inc
GPGI
+$3.2M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$547K
4
ONDS icon
Ondas Inc
ONDS
+$436K
5
LIQT icon
LiqTech
LIQT
+$267K

Top Sells

1
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.96M
2
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$2.24M
3
TEKK
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
+$990K
4
SVRE
SaverOne 2014 Ltd
SVRE
+$272K
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$31.2K

Sector Composition

1 Healthcare 21.66%
2 Consumer Discretionary 16.65%
3 Industrials 15.31%
4 Financials 13.16%
5 Materials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARR icon
51
Carrier Global
CARR
$57.6B
$213K 0.04%
6,000
– –
FLNA
52
Filana Therapeutics
FLNA
$52.2M
$209K 0.04%
5,000
– –
SLGC
53
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$203K 0.04%
70,100
– –
VATE icon
54
INNOVATE Corp
VATE
$128M
$192K 0.04%
27,480
– –
OTIS icon
55
Otis Worldwide
OTIS
$28.8B
$191K 0.04%
3,000
– –
EQRXW
56
DELISTED
EQRx, Inc. Warrant
EQRXW
$164K 0.03%
200,000
– –
PHYS icon
57
Sprott Physical Gold
PHYS
$14.3B
$161K 0.03%
12,540
– –
LGF.B
58
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$114K 0.02%
16,413
– –
ISPC icon
59
iSpecimen
ISPC
$3.18M
$109K 0.02%
82
– –
LILAK icon
60
Liberty Latin America Class C
LILAK
$1.5B
$102K 0.02%
18,174
– –
WGS icon
61
GeneDx Holdings
WGS
$1.83B
$97K 0.02%
3,333
– –
XOM icon
62
ExxonMobil
XOM
$605B
$94K 0.02%
1,075
– –
CDNS icon
63
Cadence Design Systems
CDNS
$101B
$86K 0.02%
525
– –
CMPOW
64
DELISTED
CompoSecure Inc Warrant
CMPOW
$80K 0.02%
100,000
– –
BNY
65
Bank of New York Mellon
BNY
$110B
$77K 0.02%
2,000
– –
ABBV icon
66
AbbVie
ABBV
$449B
$69K 0.01%
515
– –
XFOR icon
67
X4 Pharmaceuticals
XFOR
$361M
$61K 0.01%
1,191
– –
OPFI.WS icon
68
OppFi Inc Warrants
OPFI.WS
$60K 0.01%
250,000
– –
AMD icon
69
Advanced Micro Devices
AMD
$817B
$58K 0.01%
913
– –
MO icon
70
Altria Group
MO
$122B
$48K 0.01%
1,200
– –
LITE icon
71
Lumentum
LITE
$54.9B
$45K 0.01%
660
– –
TER icon
72
Teradyne
TER
$50.5B
$45K 0.01%
600
– –
FAZEW
73
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$41K 0.01%
75,000
– –
AENTW icon
74
Alliance Entertainment Holding Corp Warrants
AENTW
$3.77M
$38K 0.01%
200,000
– –
SVREW
75
SaverOne 2014 Ltd Warrant
SVREW
$36K 0.01%
121,000
– –
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q3 2022 Portfolio in Review

As of Q3 2022, Bleichroeder LP held 98 positions worth $479M, down 1% from $484M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bleichroeder LP's Q3 2022 filing shows 1 new, 4 increased, 1 reduced and 5 closed positions. Its largest new stake was ProKidney: 2,000,000 shares worth $18M. The largest sale was Isleworth Healthcare Acquisition Corporation Common stock, an estimated $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bleichroeder LP's largest Q3 2022 buy was ProKidney: 2,000,000 shares worth $18M.
  • Bleichroeder LP added most to GPGI Inc in Q3 2022, an estimated $3.2M increase.
  • Bleichroeder LP's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $31.2K.
  • Bleichroeder LP fully exited Isleworth Healthcare Acquisition Corporation Common stock in Q3 2022, selling an estimated $9.96M.
  • Bleichroeder LP's ten largest holdings make up 67% of its $479M portfolio in Q3 2022.
  • Bleichroeder LP opened 1 new position and closed 5 in Q3 2022.
  • Bleichroeder LP's portfolio value fell 1% quarter-over-quarter to $479M.

Based on Bleichroeder LP's 13F filing for Q3 2022, filed 14 Nov 2022.